全球穿戴式註射器市场规模（按类型、疗法、最终用户、地区、范围和预测）

穿戴式註射器市场规模及预测

2023 年穿戴式註射器市场规模价值 86.2 亿美元，预计到 2031 年将达到 187.7 亿美元，2024 年至 2031 年的复合年增长率为 10.21%。可穿戴注射器用于使用传统手持便携式设备来注射药物。它是一种自我扩展、自我管理的系统，患者可以使用它定期服药。对于患有糖尿病、肥胖症和高血压等慢性疾病的人来说，它是必不可少的。穿戴式註射器可以在仔细监控的情况下提高医疗液体的精确输送。它广泛应用于医院、家庭护理机构、诊所等。糖尿病、心血管疾病和癌症等慢性病的发生率不断上升，以及单株抗体等生物製剂在治疗疾病方面的应用日益广泛，以及智慧型手机蓝牙连接的使用日益增多，由于研发力度不断加大，市场正在不断扩大具有指纹识别和数位显示等功能的可穿戴注射器的活动。

老年患者数量的增加和家庭护理的需求正在推动市场向前发展。此外，医疗保健基础设施的完善和生活方式疾病的发生率不断增加是推动市场扩张的另外两个因素。然而，穿戴式註射器市场预计将受到新兴市场需求低和穿戴式註射器高成本的限制。

穿戴式註射器有望解决医疗保健基础设施和互联医疗服务的主要差距。由于患有慢性肺部、心血管和神经系统疾病的患者开始控制其长期影响，由于 COVID-19 导致的慢性病增加可能成为穿戴式註射器应用发展的驱动力。患有慢性病的患者要求从诊所服药改为在家服药，以避免接触新冠病毒。

穿戴式註射器的全球市场动态

影响全球穿戴式註射器市场的关键市场动态

主要市场驱动因子

慢性病发生率不断上升

糖尿病、癌症和自体免疫疾病等慢性疾病的发生率不断上升，需要频繁且精确的药物输送，因此需要一种可穿戴注射器装置来提供简单有效的治疗选择。

技术进步

穿戴式技术的技术进步，例如改进的材料、小型化和无线通信，正在提高可穿戴注射器的功能性和易用性，使其对患者和医疗保健专业人员更具吸引力。

病人对居家照护的偏好：

为了减少就诊次数和医疗费用，自我用药和居家照护正成为日益增长的趋势。穿戴式註射器为患者独立管理治疗提供了有效的解决方案。

支持性监理政策：

有利的监管框架和 FDA、EMA 等卫生当局对穿戴式註射器的日益增加的批准将推动市场成长。这些政策确保了穿戴式註射器的安全性、有效性和质量，鼓励其在临床实践中的应用。

主要问题

监管障碍与合规性：

应对复杂且具课题性的监管环境是穿戴式註射器面临的主要障碍。製造商必须确保其产品符合包括 FDA 和 EMA 在内的多个全球卫生机构的监管标准。这需要大量的测试和文件来证明安全性和有效性，这既费时又昂贵。不合规可能会导致产品审批和市场进入延迟，从而影响收入和市场竞争。

技术与设计课题：

製造一种易于使用、可靠且能够精确输送多种药物的可穿戴注射器存在重大技术障碍。将连接性和自动药物传输等先进功能结合起来，同时保持设备小巧、轻便和舒适，需要专门的工程设计。在各种天气条件和使用情况下维持设备性能使问题更加复杂。

市场接受度与采用率：

获得医疗专业人士和患者的接受和采纳至关重要，但也很困难。对新技术的不熟悉以及对安全性和有效性的担忧常常会导致抵制。克服这些障碍需要教育利益相关者，展现其好处，并确保设备可以轻鬆整合到现有的医疗保健实践中。患者的依从性也很重要，因此设计必须直观且不引人注目。

费用和报销问题：

穿戴式註射器的开发和製造成本很高，并且在定价和市场渗透方面存在课题。获得保险公司的报销对于更广泛的应用来说很重要，但如果没有成本效益和临床优势的有力证据，则会很困难。製造商必须与付款人合作制定有利的报销途径，其中可能包括昂贵的临床研究和健康经济研究。

主要趋势：

技术进步与创新：

由于穿戴式註射器配备智慧功能等技术进步，市场正在迅速扩大。这些功能包括蓝牙连接、即时监控和应用程式集成，以提高患者的依从性并为医疗保健提供者提供有用的数据。

慢性病发生率不断上升：

糖尿病、癌症和自体免疫疾病等慢性疾病的发生率不断上升，推动了对穿戴式註射器的需求。这些设备为管理长期处方方案提供了一种实用有效的方法，并透过实现家庭护理提高了患者的生活品质。

以病人为中心的医疗保健解决方案：

对以患者为中心的医疗保健的日益重视推动了可穿戴注射器的引入。这些设备的设计易于使用、可减少不适并可进行自我注射。此举使人们能够自主掌控自己的医疗护理，进一步推动了个人化医疗的趋势。

监理机关核准与市场扩张：

随着穿戴式註射器在世界各地获得监管部门的批准，市场正在开放。这不仅扩大了可用性，而且增强了客户对其安全性和有效性的信心。此外，公司正在透过策略联盟和合作来扩大其市场占有率，从而扩大其产品的影响力和采用率。

目录

第 1 章：全球穿戴式註射器市场：简介

• 市场介绍
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第 4 章：穿戴式註射器的全球市场展望

• 概述
• 市场动态
• 驱动程式
• 阻碍因素
• 机会
• 波特五力模型
• 价值链分析

第 5 章 全球穿戴式註射器市场（按类型）

• 概述
• 体内注射器
• 离体注射器

第6章 全球穿戴式註射器市场（依疗法划分）

• 概述
• 免疫肿瘤学
• 糖尿病
• 心血管疾病

第 7 章 全球穿戴式註射器市场（依最终用户划分）

• 概述
• 医院
• 家庭医疗保健
• 诊所

第 8 章 全球穿戴式註射器市场（按地区）

• 概述
• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 德国
• 英国
• 法国
• 其他欧洲国家 亚太地区
• 中国
• 日本
• 印度
• 其他亚太地区
• 世界其他地区
• 拉丁美洲
• 中东和非洲

第 9 章全球穿戴式註射器市场：竞争格局

• 概述
• 各公司的市场排名
• 主要发展策略

第10章 公司简介

• Valeritas
• SteadyMed Therapeutics
• Tandem Diabetes Care
• Amgen
• Medtronic
• Insulet Corporation
• United Therapeutic Corporation
• Enable Injections
• Ypsomed and Becton
• Dickinson and Company

第11章 附录

• 关联调查

Wearable Injector Devices Market Size And Forecast

Wearable Injector Devices Market size was valued at USD 8.62 Billion in 2023 and is projected to reach USD 18.77 Billion by 2031 , growing at a CAGR of 10.21% from 2024 to 2031. Wearable injectors are used to give drugs through a conventional handheld portable device. It is a self-scalable, self-administration system that patients use to take their medication on a regular basis. It is essential for people suffering from chronic conditions like diabetes, obesity, and hypertension. The wearable injector improves the accurate delivery of medical fluid under careful supervision. It is widely used in hospitals, home care facilities, clinics, and other settings. The market is growing due to the rising prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer, as well as the increased use of biologics such as monoclonal antibodies for disease treatment and increased R&D activities in wearable injector devices with features such as Bluetooth connectivity with a smartphone and a digital display.

The growing number of geriatric patients and demand for home-based therapy are moving the market ahead. Furthermore, the presence of well-established healthcare infrastructure, as well as an increase in the frequency of lifestyle-related disorders, are two other factors driving market expansion. However, the Wearable Injector Devices Market is projected to be restrained by low demand in developing nations and the high costs associated with wearable injectors.

Wearable injectors are expected to solve significant gaps in healthcare infrastructure and connected health services. As patients with chronic pulmonary, cardiovascular, and neurological problems begin to manage the long-term consequences of the condition, an increase in chronic ailments caused by COVID-19 morbidity may help drive development in the adoption of wearable injectors. Patients with chronic conditions are asking a switch from clinic to at-home drug administration to avoid COVID-19 exposure.

Global Wearable Injector Devices Market Dynamics

The key market dynamics that are shaping the global Wearable Injector Devices Market include:

Key Market Drivers:

Rising Prevalence of Chronic Diseases

: The rising prevalence of chronic diseases such as diabetes, cancer, and autoimmune disorders needs frequent and precise drug delivery, resulting in a desire for wearable injector devices that provide simple and effective treatment choices.

Technological Advancements

: Technological advancements in wearable technology, including as improved materials, downsizing, and wireless communication, improve the functionality and usability of wearable injectors, making them more appealing to patients and healthcare professionals.

Patient Preference for Home-Based Care:

There is a growing trend towards self-administration of medications and home-based care, fueled by the desire to reduce hospital visits and healthcare costs. Wearable injectors provide an efficient solution for patients to manage their treatment independently.

Supportive Regulatory Policies:

Favorable regulatory frameworks and increased approvals of wearable injector devices by health authorities like the FDA and EMA facilitate market growth. These policies ensure the safety, efficacy, and quality of wearable injectors, boosting their adoption in clinical practice.

Key Challenges:

Regulatory Hurdles and Compliance:

Navigating the complicated and strict regulatory landscape is a significant hurdle for wearable injector devices. Manufacturers must guarantee that their products meet the regulatory standards of several worldwide health bodies, including the FDA and EMA. This entails extensive testing and documentation to prove safety and efficacy, which can be time-consuming and expensive. Non-compliance can cause delays in product approval and market access, affecting revenue and competitiveness.

Technological and Design Challenges:

Creating wearable injector devices that are user-friendly, dependable, and capable of precisely delivering a wide range of drugs has substantial technical obstacles. Keeping the gadgets small, lightweight, and comfy while combining advanced capabilities like connection and automated drug delivery necessitates expert engineering. Maintaining device performance under a variety of weather settings and usage scenarios further complicates matters.

Market Acceptance and Adoption:

Gaining acceptance and adoption from healthcare professionals and patients is crucial but difficult. Unfamiliarity with new technologies, as well as concerns about safety and efficacy, frequently cause resistance. Overcoming these barriers requires educating stakeholders, demonstrating advantages, and ensuring that the devices integrate easily into existing healthcare practices. Patient adherence is also critical, thus designs must be intuitive and least obtrusive.

Cost and Reimbursement Issues:

Wearable injector devices can be costly to develop and manufacture, offering pricing and market penetration challenges. Receiving reimbursement from insurance companies is critical for wider adoption, but this can be difficult without strong evidence of cost-effectiveness and clinical advantages. Manufacturers must collaborate with payers to build advantageous reimbursement routes, which can include costly clinical studies and health economic studies.

Key Trends:

Technological Advances and Innovations:

The market is expanding rapidly as a result of technological advances such as the incorporation of smart features into wearable injectors. These features include Bluetooth connectivity, real-time monitoring, and app integration, which improve patient compliance and give useful data to healthcare providers.

Increasing Prevalence of Chronic Diseases:

The growing prevalence of chronic diseases such as diabetes, cancer, and autoimmune disorders is fueling demand for wearable injectors. These devices provide a practical and effective approach to managing long-term prescription regimens, enhancing patient quality of life by allowing for at-home care.

Patient-Centered Healthcare Solutions:

The rising emphasis on patient-centered healthcare is driving the introduction of wearable injectors. These devices are designed to be user-friendly, reducing discomfort and allowing for self-administration. This move advances the trend of individualized medicine by empowering people to manage their own care.

Regulatory Approvals and Market Expansion:

The market is developing as more wearable injectors obtain regulatory authorization around the world. This not only expands their availability but also raises customer trust in their safety and efficacy. Furthermore, organizations are increasing their market presence through strategic alliances and collaborations, which improve product reach and adoption.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Wearable Injector Devices Market Regional Analysis

Here is a more detailed regional analysis of the global Wearable Injector Devices Market:

North America:

North America has a well-developed healthcare infrastructure that facilitates the introduction of innovative medical technologies, such as wearable injector devices. The existence of world-class hospitals, research institutions, and healthcare facilities enables the rapid integration of these devices into patient care. Furthermore, the region has strong healthcare funding and reimbursement rules that promote innovation and use of cutting-edge medical technologies.

The increased prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disease in North America fuels demand for wearable injector devices. These devices provide a simple and effective way to manage long-term pharmaceutical regimens, which is critical for patients with chronic diseases. The growing number of patients requiring ongoing therapy creates a significant market for these advanced drug delivery systems.

North America's strong regulatory environment protects the safety and efficacy of medical products, boosting consumer confidence. Regulatory bodies such as the FDA establish clear guidelines and pathways for the approval and commercialization of wearable injectors. This regulatory support not only speeds up the introduction of innovative technologies to the market, but it also reassures healthcare providers and patients about their dependability.

The region is a hotbed of technical innovation and healthcare-related research and development. Companies and research organizations in North America are investing extensively in next-generation wearable injectors with advanced features including connectivity and real-time monitoring. This ongoing focus on innovation improves product offerings and establishes North America as a market leader in wearable injector devices.

Asia Pacific:

Asia Pacific is experiencing significant expansion in healthcare infrastructure, which is fueling the growth of the Wearable Injector Devices Market. Governments throughout the area are raising healthcare budgets and investing in cutting-edge medical technologies to improve patient care. This investment promotes the use of novel equipment such as wearable injectors in hospitals and clinics. Improved healthcare facilities attract a larger patient population, which fuels market expansion.

Diabetes, cancer, and cardiovascular disease are all on the rise in the region. This surge in chronic illnesses needs long-term and efficient treatment alternatives, making wearable injectors an intriguing solution. These technologies enable patients to manage their diseases at home, minimizing the need for frequent hospital visits. The expanding patient population, with chronic diseases boosts the demand for wearable injectors.

Economic expansion in countries such as China, India, and Japan is resulting in increasing disposable incomes and healthcare spending among the population. People with larger financial means are more inclined to invest in innovative healthcare solutions, such as wearable injector devices. Furthermore, increased healthcare knowledge and education are encouraging people to seek out better and more convenient treatment options, hence promoting market growth.

The regulatory climate in Asia Pacific is becoming more conducive to medical device innovation and commercialization. Governments are creating favorable regulations and expediting the approval process for new medical technologies. This creates a favorable environment for the introduction and use of wearable injector devices. The ease with which regulatory licenses are granted increases market entry and expansion for regional producers and distributors of such devices.

Global Wearable Injector Devices Market: Segmentation Analysis

The Global Wearable Injector Devices Market is Segmented on the basis of Type, Therapy, End-User, And Geography.

Wearable Injector Devices Market, By Type

• On-Body Injectors
• Off-Body Injectors

Based on Type, the market is segmented into On-Body Injectors and Off-Body Injectors. On-body wearable injectors accounted for the greatest revenue share in 2023, owing to rising demand because these patches are pleasant to wear on the skin (stomach), are water resistant, and are convenient to use at home. On-body wearable injectors have several advantages, including fewer hospital visits, lower healthcare costs, lifecycle management, customizable dosing, and automatic warming of cold medications. Off-body wear removes hazards such as painful device removal, adhesive fitting difficulties, and skin sensitivity or irritation.

Wearable Injector Devices Market, By Therapy

• Immuno-Oncology
• Diabetes
• Cardiovascular Diseases

Based on Therapy, The market is segmented into Immuno-Oncology, Diabetes, and Cardiovascular Diseases. During the projection period, the diabetes category has the most share. This category's significant position may be attributable to the rising prevalence of diabetes worldwide, as well as the increasing availability of wearable injectors for the treatment of chronic diseases, which is moving this market segment forward.

Wearable Injector Devices Market, By End-User

• Hospitals
• Home Care Settings
• Clinics

Based on End-User, The market is segmented into Hospitals, Home Care Settings, and Clinics. The hospital and clinic segment has a larger market share. The growing preference for self-administration of medication, as well as the growing need to cut healthcare costs, can be attributed to this segment's significant share. Furthermore, the growing need for technologically advanced drug administration systems that lower hospitalization rates while requiring minimal expertise is expected to drive the home healthcare settings market ahead.

Wearable Injector Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, The Global Wearable Injector Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The Wearable Injector Devices Market in North America is the world's largest. The high prevalence of chronic and lifestyle-related illnesses, as well as the availability of advanced healthcare infrastructure in the region, account for North America's large share of this market.

Key Players

• The "Global Wearable Injector Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Valeritas, SteadyMed Therapeutics, Tandem Diabetes Care, Amgen, Medtronic, Insulet Corporation, United Therapeutic Corporation, Enable Injections, Ypsomed and Becton, Dickinson and Company.
• The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

• Wearable Injector Devices Market Recent Developments
• In February 2023, Insulet Corporation purchased the assets of Automated Glucose Control LLC (AGC), a firm dedicated to developing and marketing best-in-class automated insulin delivery technology. The company participated in the creation of Omnipod (Insulet's flagship product).
• In January 2023, Tandem purchased Capillary Biomedical, an infusion set developer.
• In July 2022, Becton Dickinson and Company purchased Parata Systems. This acquisition will assist BD's market growth.
• In January 2022, enable injections were obtained. The company obtained USD 215 million in Series C investment. The cash will be used to onboard Enable Injections and major new pharma partner initiatives, as well as to speed the commercialization of their products and platforms with existing pharma partners.
• In September 2021, Ypsomed AG introduced the YpsoDose single-use injector, which is an electromechanical pre-filled and pre-assembled patch device for 10 mL glass cartridges. Automatically completed steps include needle insertion, injection, end-of-injection feedback, and needle safety. The needle is kept hidden at all times and is rendered safe following injection and device removal.

TABLE OF CONTENTS

1. Introduction of Global Wearable Injector Devices Market

• Introduction of the Market
• Scope of Report
• Assumptions

2. Executive Summary

3. Research Methodology of Verified Market Research

• Data Mining
• Validation
• Primary Interviews
• List of Data Sources

4. Global Wearable Injector Devices Market Outlook

• Overview
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Porters Five Force Model
• Value Chain Analysis

5. Global Wearable Injector Devices Market, By Type

• Overview
• On-Body Injectors
• Off-Body Injectors

6. Global Wearable Injector Devices Market, By Therapy

• Overview
• Immuno-Oncology
• Diabetes
• Cardiovascular Diseases

7. Global Wearable Injector Devices Market, By End-User

• Overview
• Hospitals
• Home Care Settings
• Clinics

8. Global Wearable Injector Devices Market, By Geography

• Overview
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Rest of the World
• Latin America
• Middle East & Africa

9. Global Wearable Injector Devices Market Competitive Landscape

• Overview
• Company Market Ranking
• Key Development Strategies

10. Company Profiles

• Valeritas
• SteadyMed Therapeutics
• Tandem Diabetes Care
• Amgen
• Medtronic
• Insulet Corporation
• United Therapeutic Corporation
• Enable Injections
• Ypsomed and Becton
• Dickinson and Company

11. Appendix

• Related Research